A system approach to improving guideline-directed therapy for cardio-renal-metabolic conditions: The “beyond diabetes” initiative

OBJECTIVE: Despite demonstrating improvements in cardiovascular disease, kidney disease, and survival outcomes, guideline-directed antihyperglycemic medications such as sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like-peptide-1 receptor agonists (GLP1-RA), are underutilized. Many...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirsh, Benjamin J., Hirsch, Jamie S., Hmoud, Hosam, Weintraub, Spencer, Cha, Agnes, Lesser, Martin, Huang, Xueqi, Xie, Yan Yan Sally, Nahrwold, Rachel, Joshua, John, Scanlon, Jennifer, Galella, Thomas, Singh, Varinder, Gianos, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562667/
https://www.ncbi.nlm.nih.gov/pubmed/37822579
http://dx.doi.org/10.1016/j.ajpc.2023.100608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562667/
https://www.ncbi.nlm.nih.gov/pubmed/37822579
http://dx.doi.org/10.1016/j.ajpc.2023.100608

Ejemplares similares